nLite 360® - AI Gen 2

nLite 360® – AST I3

nLite360® – BST I3

nlitePad

About Us

Neonatal Jaundice

Globally, Healthcare providers worldwide recognize that severe neonatal jaundice is a “silent” cause of significant neonatal morbidity and mortality.
01.

New born baby care

02.

nLite your baby health

black-arrow Know More

Over 60% of all newborns develop neonatal jaundice

56 +

Around 15% to 45% of newborns develop severe neonatal jaundice in developing countries

360 +

Around 10% of newborns die due to neonatal jaundice all over the world

89 K

Almost 20% of the jaundice babies in india alone ,die due to severe neonatal jaundice

42 +

Our Solutions

High Quality Solutions
for new born babies.

Introducing A smart Design approached technology
A Revolutionary Phototherapy device for neonatal jaundice management.

Challenges

Current
Treatment Challenges

SLOW TREATMENT
01

SLOW TREATMENT

Existing treatments result in a prolonged 2-3 week delay, impacting timely care for infants.
SEVERE JAUNDICE CONDITION
02

SEVERE JAUNDICE CONDITION

Blood transfusion and current indigenous methods fall short in effectively addressing severe jaundice cases.
POST-NATAL SEPARATION
03

POST-NATAL SEPARATION

Immediate separation after birth causes anxiety and disrupts the crucial initial bond between newborns and mothers.
LOW EFFICIENCY
04

LOW EFFICIENCY

Treatment efficiency is hindered by factors such as suboptimal irradiance, inadequate body surface exposure, and insufficient breastfeeding.

Home Phototherapy

Neonatal care at your Doorstep From an IIT Hyderabad startup

*Ensuring Newborn Joy under Expert Guidance

People Trusted

Our Partnering Doctor

DR. SWAPNA. LINGALDINNA


Associate PROFESSOR OF NEONATOLOGY NILOUFER HOSPITAL, HYDERABAD.

“I’m thrilled to partner with HEAMAC! Their innovative phototherapy devices have significantly improved newborn care, and I’m proud to be part of this journey.”

Heamac

Supported By

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

The feedback system provides optimum amount of irradiance, and the portable version provides treatment at mothers ward itself.

Dr. Swapna

Neonatologist, Neloupher Maternal and Children Govt. Hospital.

The device is having triple surface Phototherapy, so there is less heating and dehydration of the baby and since it can also be titrated the level of irradiance the jaundice will reduce faster and also avoid blood transfusions.

Dr. Alimelu, HOD

Neonatology Dept. Neloupher Maternal and Children Govt. Hospital, Prof. Neonatology Osmania Medical College.

As the product supports both standalone and portable versions, we can use it for both critical cases in NICU and treat the baby at home with mild jaundice

Dr. Suresh

Peidtaician, DCH, MBBS, Neloupher Maternal and Children Hospital

As the product supports both standalone and portable versions, we can use it for both critical cases in NICU and treat the baby at home with mild jaundice

Dr. Bezawada Prasanth Babu

Pediatrition, DCH, MBBS Kamineni hospitals, Hyderabad.

I recommend HEAMAC Phototherapy as it gives continuous therapy, and it adjusts the intensity to avoid over or under treatment.

Dr. Manoj Kumar

Neonatologist, Vellamal Hospital, Madurai.

The intelligent feedback module help to treat the baby in remote area even with low skilled staff.

Dr.Srinivas Murki

(Paediatrician) Fernandez Children Hospital, Hyderabad.

Heamac

Our Clients

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

Client-03

WhatsApp Icon